Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Teclistamab in Systemic AL Amyloidosis: a Multi-center Prospective Study

NCT06699394 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT06699394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Teclistamab in Systemic AL Amyloidosis: a Multi-center Prospective Study
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 29, 2025
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

al amyloidosis